Clinical Trial

The Cancer of the Pancreas Screening-5 CAPS5)Study

Study acronym: CAPS5
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Protocol Amendment History 38 amendments
This ClinicalTrials.gov record has been amended 38 times since 2013-11-26; most recent amendment 2025-10-08.
Status change: Not Yet Recruiting → Recruiting 2014-05-28
Trial Details
NCT Number NCT02000089
Lead Sponsor Johns Hopkins University
Collaborators: National Cancer Institute (NCI), National Institutes of Health (NIH), American Association for Cancer Research
Conditions Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation, Germline Mutation Carrier, Lynch Syndrome
Enrollment 9,000 participants
Start Date 2014-01-06
Primary Completion 2028-12 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2025-10-09